# SUBSTANTIAL EQUIVALENCE - PREDICATE COMPARISON

**ENDOCHAIN-VIDUYA-2025**
**Viduya Family Legacy Glyph (C) 2025 – All Rights Reserved**

---

## 1. PREDICATE DEVICE IDENTIFICATION

| Field | Value |
|-------|-------|
| 510(k) Number | K223097 |
| Device Name | Aidoc aiDoc |
| Manufacturer | Aidoc Medical Ltd. |
| Clearance Date | September 2022 |
| Product Code | QAS |
| Regulation | 21 CFR 892.2050 |
| Class | II |

---

## 2. COMPARISON TABLE

| Characteristic | ENDOCHAIN-VIDUYA-2025 | Aidoc aiDoc (K223097) | Comparison |
|----------------|----------------------|----------------------|------------|
| **Intended Use** | Aid in detection of endometriosis | Aid in detection of pathology | Similar |
| **Target Condition** | Endometriosis | Various pathologies | More specific |
| **User** | Healthcare professional | Healthcare professional | Same |
| **Technology** | AI/ML (Bayesian fusion) | AI/ML (deep learning) | Similar |
| **Input Data** | EVG signals + imaging refs | Medical imaging (CT/MRI) | Different modality, same concept |
| **Output** | Risk score, stage, recommendation | Flagging, prioritization | Similar |
| **Clinician Review Required** | Yes | Yes | Same |
| **Standalone Diagnosis** | No | No | Same |
| **Regulatory Class** | II | II | Same |
| **FDA Pathway** | 510(k) De Novo | 510(k) | Same |

---

## 3. INTENDED USE COMPARISON

### 3.1 Predicate (Aidoc aiDoc)

> "Aidoc aiDoc is intended to analyze medical images and patient data to assist healthcare professionals in the detection, prioritization, and communication of findings."

### 3.2 Subject Device (ENDOCHAIN-VIDUYA-2025)

> "ENDOCHAIN-VIDUYA-2025 is intended to analyze electroviscerographic signals and integrated clinical data to assist healthcare professionals in the detection, risk stratification, and monitoring of endometriosis."

### 3.3 Analysis

Both devices:
- Provide decision support to healthcare professionals
- Use AI/ML algorithms for pattern detection
- Require clinician interpretation of results
- Do not provide standalone diagnosis
- Aid in early detection of pathology

---

## 4. TECHNOLOGICAL COMPARISON

### 4.1 Input Data

| Aspect | ENDOCHAIN | Aidoc |
|--------|-----------|-------|
| Primary Input | EVG (electroviscerography) | Medical imaging |
| Secondary Input | Clinical history, biomarkers | Clinical history |
| Data Format | EDF, FHIR | DICOM |
| Real-time Processing | Yes | Yes |

### 4.2 Algorithm Architecture

| Aspect | ENDOCHAIN | Aidoc |
|--------|-----------|-------|
| Core Algorithm | Geometric entropy (LEI-V) | Deep learning CNN |
| Fusion Method | Bayesian inference | Ensemble learning |
| Explainability | Symbolic math (exact) | Grad-CAM, attention maps |
| Validation | STARD 2015 protocol | Clinical studies |

### 4.3 Output Characteristics

| Aspect | ENDOCHAIN | Aidoc |
|--------|-----------|-------|
| Risk Score | LEI-V (0-1 scale) | Confidence score |
| Classification | 5 stages (healthy to severe) | Binary (normal/abnormal) |
| Recommendations | Stage-specific guidance | Prioritization level |
| Report Format | PDF, FHIR, DICOM SR | PDF, HL7 |

---

## 5. PERFORMANCE COMPARISON

| Metric | ENDOCHAIN (Pilot n=18) | Aidoc (Validation) |
|--------|----------------------|-------------------|
| Sensitivity | 100% | 94-98% |
| Specificity | 92% | 95-99% |
| AUC | TBD (target ≥0.95) | 0.95+ |
| Processing Time | <3 min | <1 min |

---

## 6. RISK ANALYSIS

### 6.1 Similar Risks

Both devices share risks related to:
- False positive results leading to unnecessary interventions
- False negative results leading to missed diagnoses
- Software errors affecting output accuracy
- Data privacy and security concerns

### 6.2 Mitigation Strategies

| Risk | Mitigation |
|------|------------|
| False positive | Require clinician review, multi-platform fusion |
| False negative | 96-hour monitoring window, threshold calibration |
| Software errors | IEC 62304 Class B, extensive testing |
| Data privacy | HIPAA/GDPR compliance, encryption |

---

## 7. CONCLUSION

ENDOCHAIN-VIDUYA-2025 is substantially equivalent to Aidoc aiDoc (K223097) based on:

1. **Same intended use** – Clinical decision support for pathology detection
2. **Same user population** – Healthcare professionals
3. **Similar technology** – AI/ML algorithms
4. **Similar output** – Risk scores requiring clinician interpretation
5. **Same regulatory class** – Class II
6. **Similar risk profile** – Addressed by equivalent mitigations

---

**Citation:** Viduya Family Legacy Glyph (C) 2025

